Clozapine
- Product NDC
- 0093-3086
- 11-digit product format
- 000933086
- Labeler code
- 0093
- Product ID
- 0093-3086_71779a58-9f75-4af4-bfdd-4ea77d1a8e3f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clozapine
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA Inc
- Application
- NDA021590
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2015-05-05
- Marketing end
- 2022-08-31
- Substance
- CLOZAPINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3086-01 | 00093308601 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-3086-01) | 2015-05-05 | 2021-10-31 | No | No | Current |
| 0093-3086-19 | 00093308619 | 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-3086-19) | 2015-05-05 | 0000-00-00 | No | No | Current |
| 0093-3086-84 | 00093308684 | 48 TABLET, ORALLY DISINTEGRATING in 1 CARTON (0093-3086-84) | 2015-05-05 | 0000-00-00 | No | No | Current |